Provided By GlobeNewswire
Last update: Jul 2, 2025
IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company focused on innovative gastroenterology diagnostics, today announced that the American Medical Association CPT editorial panel has issued a Current Procedural Terminology (CPT®) code in the Proprietary Laboratory Analysis (PLA) code category for the Company’s inFoods® IBS test.
Read more at globenewswire.comNASDAQ:BMRA (8/8/2025, 8:21:20 PM)
3.11
0 (0%)
Find more stocks in the Stock Screener